MacuCLEAR

About:

MacuCLEAR focuses on discovering and developing novel solutions for vascular disorders of the eye.

Twitter/X: MacuCLEAR

Description:

MacuCLEAR Inc.™ is a specialty clinical-stage pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye. MacuCLEAR has an active IND for MC-1101 and has completed a novel and successful Phase Ib/POC human clinical trial.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Plano, Texas, United States

Founded Date:

2006-01-01

Contact Email:

csojda(AT)tiberend.com

Founders:

George Chiou

Number of Employees:

11-50

Last Funding Date:

2012-01-03

IPO Status:

Private

Industries: